Inflammatory Challenge and Fear
University of California, San Francisco · with National Institute of Mental Health (NIMH), Northern California Institute of Research and Education · NCT06630884
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 288
- US sites recruiting
- 1
- Study start
- March 28, 2025
- Record last updated
- September 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to learn if short-term changes in the immune system alter how we process information and experience fear. The main questions it aims to answer are:
Do people who receive typhoid vaccine respond differently than those who receive a placebo saline vaccine? Do people who receive typhoid vaccine experience changes in how they think and feel?
Participants will
Attend four appointments at the San Francisco VA Health Care System;
Receive typhoid vaccine or placebo at one of the visits;
Have their physiological responding measured while listening to sounds;
Complete questionnaires and psychological tests.
Being studied: Typhoid VI Polysaccharide Vaccine Injectable Solution; Saline Placebo (0.5mL injection)
Conditions: Posttraumatic Stress Disorder (PTSD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
All Subjects
- Aged 18-65 years old
- Trauma Exposed
- Current PTSD/No history of PTSD
Exclusion Criteria
- Contraindications to typhoid vaccine
- Conditions associated with inflammation
- Pregnancy or plans to become pregnant in next three months
Recruiting US locations
San Francisco VA Health Care System
San Francisco, CA 94121
Study contacts (from the official record)
- Aoife O'Donovan, PhD · 415-221-4810 · aoife.odonovan@ucsf.edu
- Michael Srouji, BA · 415-221-4810
Similar studies in California
All mental health studies in California →- RecruitingHealthy volunteersEarly Phase 1
Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Neurosterix
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Los Alamitos, CA + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- Anaheim, CA + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersEarly Phase 1
Mental Health in Veterans and Families After Group Therapies
Soul Medicine Institute
- Location
- Santa Rosa, CA
- Eligibility basics
- Ages 18–80